BIO Joins Diverse Coalition Promoting Market-Based Solutions to Address Prescription Drug Costs, Increase Patient Access and Choice

May 17 2017

Washington, DC (May 17, 2017) – Today, the Biotechnology Innovation Organization (BIO) joins with a diverse coalition of stakeholders in endorsing a set of pro-competition,...

BIO Submits Comments to EPA Regulatory Reform Task Force

May 16 2017
BIO submitted comments to the Environmental Protection Agency’s Regulatory Reform Task Force on Executive Order 13777 “Enforcing the Regulatory Reform Agenda.”

BIO Statement on the Passing of Biotechnology Giant Henri Termeer

May 15 2017

Termeer was a key architect in the founding of BIO, a mentor to countless entrepreneurs, executives and researchers, and passionate in his pursuit of innovative patient...

BIO Statement on U.S.-China Comprehensive Economic Dialogue

May 12 2017
Washington, D.C. (May 12, 2017) – The Biotechnology Innovation Organization (BIO) issued the following statement regarding initial results of the 100-Day Action Plan of the U.S.-China Comprehensive Economic Dialogue:

Convention Programming to Feature “One Health” Concept

May 11 2017
Bio-based Technologies Address Human, Animal, Plant and Environmental Health Washington, D.C. (May 11, 2017) – At its heart, the concept of One Health is rooted in the notion that the health of humans, animals, and the environment are all interconnected. At BIO’s 2017 International Convention (June 19-22 in San Diego), programming will feature the One Health concept through stories that show how science and technology are making tomorrow’s breakthroughs possible.  

Ann Romney to Deliver Keynote at 2017 BIO International Convention

May 10 2017
Former First Lady of Massachusetts and New York Times best-selling author will speak about the power of resilience in overcoming obstacles, advocating for families and spearheading brain health research

BIO Congratulates Dr. Scott Gottlieb on Confirmation as FDA Commissioner

May 9 2017
Washington, DC (May 9, 2017) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding the confirmation of Dr. Scott Gottlieb as Commissioner of the Food and Drug Administration (FDA):

BIO Thanks Sen. Wyden for Clean Fuel Production Tax Credit Proposal

May 4 2017
BIO today thanked Sen. Ron Wyden (D-OR) and 21 Senate co-sponsors for proposing a technology neutral tax credit for domestic production of clean transportation fuel. Sen. Wyden’s Clean Energy for America Act proposes a set of long-term energy tax incentives that are available to all technologies and promote performance based clean energy in the United States. BIO supports Sen. Wyden’s efforts to ensure that any tax reform package Congress considers includes incentives that promote the development and production of advanced and cellulosic biofuels.

BIO Applauds Bipartisan Introduction of the PARTNER Act

May 4 2017
Washington, DC (May 4, 2017) – Today, the Biotechnology Innovation Organization (BIO) thanks Reps. Pat Meehan (R-PA), Richard Neal (D-MA), Mike Kelly (R-PA), Ron Kind (D-WI), and John Larson (D-CT) for introducing the Partnerships to Advance Revolutionary Technology and Novel Entrepreneurial Research (PARTNER) Act.  This important legislation would support early-stage capital formation by incentivizing investment in R&D-focused small businesses.

BIO Partners with NIH and NSF for Fourth “Innovation Zone” Exhibit

May 4 2017
SBIR-funded companies will showcase biotechnology breakthroughs at BIO 2017 International Convention